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Cerebral metabolism is compartmentalized between neurons and glia. Although glial
glycolysis is thought to largely sustain the energetic requirements of neurotransmission
while oxidative metabolism takes place mainly in neurons, this hypothesis is matter of
debate. The compartmentalization of cerebral metabolic ﬂuxes can be determined by 13C
nuclear magnetic resonance (NMR) spectroscopy upon infusion of 13C-enriched com-
pounds, especially glucose. Rats under light α-chloralose anesthesia were infused with
[1,6-13C]glucose and 13C enrichment in the brain metabolites was measured by 13C NMR
spectroscopy with high sensitivity and spectral resolution at 14.1 T. This allowed deter-
mining 13C enrichment curves of amino acid carbons with high reproducibility and to
reliably estimate cerebral metabolic ﬂuxes (mean error of 8%).We further found that TCA
cycle intermediates are not required for ﬂux determination in mathematical models of
brain metabolism. Neuronal tricarboxylic acid cycle rate (VTCA) and neurotransmission rate
(V NT) were 0.45± 0.01 and 0.11± 0.01μmol/g/min, respectively. Glial VTCA was found to
be 38± 3% of total cerebral oxidative metabolism, accounting for more than half of neu-
ronal oxidative metabolism. Furthermore, glial anaplerotic pyruvate carboxylation rate (V PC)
was 0.069± 0.004μmol/g/min, i.e., 25± 1% of the glialTCA cycle rate.These results sup-
port a role of glial cells as active partners of neurons during synaptic transmission beyond
glycolytic metabolism.
Keywords: glucosemetabolism, neurotransmission,mathematical modeling, NMR spectroscopy, neurotransmitter
metabolism
INTRODUCTION
Cerebral function depends on coordinated interaction of distinct
cell types, namely neurons and glial cells, and relies on high meta-
bolic activity that is supported by continuous and adequate supply
of glucose and oxygen from the blood stream (Siesjo, 1978). Reg-
ulation of neuronal-glial cooperation at metabolic level involves
the mechanism of deactivation of the major excitatory neuro-
transmitter, glutamate, through glial uptake and conversion to
electrophysiologically inactive glutamine, which is then trans-
ported back to the neuron to replenish the neurotransmitter pool
of glutamate (see revision byZwingmann and Leibfritz, 2003). The
maintenance of this exchange of glutamate and glutamine between
neurons and glia requires energy provided by glucose oxidation in
glycolysis and tricarboxylic acid (TCA) cycle (e.g., Sibson et al.,
1998).
Although brain activity relies on blood glucose, it is not
excluded the possibility of lactate exchange between metabolic
Abbreviations: ATP, Adenosine-5′-triphosphate; FE, fractional enrichment; NMR,
nuclear magnetic resonance; PCA, perchloric acid; TCA, tricarboxylic acid.
compartments. In fact, a putative lactate shuttle is thought to exist
from astrocytes to neurons (Magistretti et al., 1999). According to
this hypothesis,most glucose is oxidized to lactate in astrocytes and
the resulting adenosine-5′-triphosphate (ATP) sufﬁces to main-
tain glutamate clearance from the synaptic cleft and conversion
to glutamine. The produced lactate is transferred to neurons for
oxidative degradation (Pellerin and Magistretti, 1994; Magistretti
et al., 1999). Based on this hypothesis, glial metabolism has been
thought to be mostly glycolytic (Sibson et al., 1998; Shulman et al.,
2003), which is controversial (e.g., Dienel and Hertz, 2001; Gjedde
and Marrett, 2001; Simpson et al., 2007; Mangia et al., 2009). Fur-
thermore, astrocytic uptake of glutamate could also be fueled by
ATP of mitochondrial origin (Dienel and Hertz, 2001) and, in fact,
the glial TCAcyclewas found to account for 30%of total TCAcycle
activity in the conscious rat brain (Oz et al., 2004). A substantial
fraction of mitochondrial oxidation in astrocytes occurs through
pyruvate carboxylase and was suggested to increase with cerebral
activity (Sibson et al., 1998; Choi et al., 2002; Oz et al., 2004).
The compartmentalization of these metabolic pathways and
inter-compartmental interactions have been studied by non-
invasive 13C nuclear magnetic resonance (NMR). Dynamic
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in vivo 13C NMR spectroscopy combined with the infusion of
13C-enriched substrates and followed by appropriate mathemat-
ical modeling was proved to be a powerful tool for studying
the compartmentalized cerebral metabolism. Although brain cells
have the ability of using several substrates, glucose is well estab-
lished as the main fuel for cerebral metabolism (Siesjo, 1978).
The most determined metabolic rates upon infusion of 13C-
enriched glucose include glucose utilization (CMRglc), neuronal,
and glial TCA cycles (V TCA), the malate–aspartate shuttle activity
(V x), apparent neurotransmission ﬂux (V NT), i.e., glutamate–
glutamine cycle, and glial anaplerotic pyruvate carboxylation
(V PC) (e.g., Sibson et al., 1998; Gruetter et al., 2001; Oz et al.,
2004; Patel et al., 2005). However, strong debate is continuously
generated on the relative values for these metabolic ﬂuxes and
how should they be properly determined (Shestov et al., 2007;
Uffmann and Gruetter, 2007; Shen et al., 2009). Many assump-
tions are generally used for in vivo determination of metabolic
ﬂuxes and concern has been raised on the reliability of estimated
ﬂuxes from experiments using 13C-enriched glucose as metabolic
tracer (Shestov et al., 2007; Shen et al., 2009).
We tested the hypothesis that high sensitivity and resolution
achieved in 13C NMR spectra at 14.1 T leads to increased reliabil-
ity in detected 13C enrichment time courses and thus allows us to
determine accurate metabolic ﬂuxes. In fact, the present data was
acquired with high temporal resolution, during approximately 6 h
andwith lownoise level,which are conditions required for accurate
ﬂux estimation (Shestov et al., 2007). In addition, although most
mathematical models were designed with many unknown meta-
bolic pools, namely for TCA cycle intermediates, a simpliﬁcation
has been proposed and resulted in a mathematical model where
ﬂux estimation is mostly dependent on 13C enrichment of mea-
sured metabolites (Uffmann and Gruetter, 2007). The comparison
between these two approaches was now performed. For the ﬁrst
time we show experimental evidence supporting that TCA cycle
intermediates are not required in mathematical models of cerebral
metabolism, as previously suggested by mathematical simulations
(Uffmann and Gruetter, 2007).
In this study,metabolic ﬂuxeswere determinedwith higher pre-
cision than in previous 13C NMR studies in the brain of rodents
(e.g., Choi et al., 2002; Patel et al., 2005) or humans (e.g., Gruetter
et al., 2001), as depicted by an average associated error of 8%. We
identiﬁed substantial pyruvate carboxylation and glial TCA cycle
rates that together accounted formore than half of neuronalV TCA,
suggesting high glial oxidative metabolism.
MATERIALS AND METHODS
ANIMALS
All experimental procedures involving animals were approved by
the local ethics committee. Male Sprague-Dawley rats (276 ± 11 g,
n = 5,obtained fromCharles River Laboratoires,France)were pre-
pared as previously described (Duarte et al., 2009a). Brieﬂy, after
fasting for 6 h, rats were anesthetized using 2% isoﬂurane (Attane,
Minrad, NY, USA) in 30% oxygen in air, and then intubated with
an endotracheal catheter and ventilated with a pressure-driven
ventilator (MRI-1, CWE incorporated, PA, USA). Catheters were
inserted into a femoral artery for monitoring blood gases, glucose,
lactate, and arterial blood pressure, and into a femoral vein for
infusion of saline solutions containing α-chloralose (AcrosOrgan-
ics, Geel, Belgium) or [1,6-13C]glucose (Isotec, Sigma-Aldrich,
Basel, Switzerland).
Animalswere immobilized in a homebuilt holderwith a bite bar
and two ear inserts to minimize potential motion. Body tempera-
ture was maintained between 37.0 and 37.5˚C with a warm water
circulation system based on the feedback obtained from a home-
built rectal temperature probe. Arterial blood pressure, heart rate,
and respiratory rate were continuously monitored with an animal
monitoring system (SA Instruments, NY, USA). Before inserting
the animal in the bore of the magnet, anesthesia was switched
to α-chloralose (intravenous bolus of 80 mg/kg and continuous
infusion rate of 28mg/kg/h). Arterial pH and pressures of O2 and
CO2 were measured using a blood gas analyzer (AVL Compact
3, Diamond Diagnostics, MA, USA). Plasma glucose and lactate
concentrations were quantiﬁed with the glucose or lactate oxi-
dase methods, respectively, using two multi-assay analyzers (GW7
Micro-Stat, Analox Instruments, London, UK).
The glucose infusion procedure was adapted from the proto-
col described by Henry et al. (2003a). Brieﬂy, a bolus of 99.9%
enriched [1,6-13C]glucose (1.1 M in saline solution) was given at
a 5-min exponential decay based on the measured basal glycemia
and aiming at 70% plasma fractional enrichment (FE). After the
bolus, 70% enriched [1,6-13C]glucose (1.1M in saline solution)
was infused at a rate equivalent to the whole body glucose disposal
rate of 33.2 mg/kg/min (Jucker et al., 2002) and adjusted based on
concomitantly measured arterial plasma glucose concentrations.
Plasma samples were stored at −80˚C for determination of sub-
strate FE. Arterial pH and blood gases were maintained within
the normal physiological range by adjusting respiratory rate and
volume.
IN VIVO NMR SPECTROSCOPY
All in vivo NMR experiments were carried out in a DirectDrive
spectrometer (Varian, Palo Alto, CA, USA) interfaced to a 14.1 T
magnet with a 26-cm horizontal bore (Magnex Scientiﬁc, Abing-
don, UK), using a homebuilt coil consisting of a 1H quadrature
surface coil and a 13C linearly polarized surface coil. The rat brain
was positioned in the isocenter of the magnet and fast-spin-echo
images with repetition time of 5 s, echo time of 52 ms and echo
train length of eight allowed to identify anatomical landmarks,
which were used to place the volume of interest (VOI) of 320 μL
in the brain. Shimming was performed with FAST(EST)MAP
(Gruetter and Tkác, 2000). Localized 1H NMR spectra were
acquired using SPECIAL (Mlynárik et al., 2006) with echo time of
2.8ms and repetition time of 4 s. 13C NMR spectra were acquired
using semi-adiabatic distortionless enhancement by polarization
transfer (DEPT) combined with 3D-ISIS 1H localization (Henry
et al., 2003a).
Spectral analysis was carried out using LCModel (Stephen
Provencher Inc., Oakville, ON, Canada) for both 1H (Mlynárik
et al., 2006) and 13C NMR spectra (Henry et al., 2003b). Simula-
tion of basis spectra for the observable isotopomerswas performed
in Matlab (The MathWorks, Natick, MA, USA) as described by
Henry et al. (2003b). The scaling of dynamically measured 13C
concentrations was based on the FE of glutamate C3, which was
determined through themultiplicity of glutamate C4, and the total
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glutamate concentration obtained from 1H NMR spectra. In other
words, FE of glutamate C3 was determined from the C4 reso-
nance in 13C spectra from the last 20min, assuming steady-state
for C4 enrichment and FE(C3)=C4D34/(C4S+C4D34). Then,
relative intensities in 13C NMR spectra were used to scale 13C
concentration for all carbon resonances through all time courses.
Additionally, in vitro 13C NMR spectra from brain extracts and
standard solutions including the metabolites of interest allowed
correcting for the relative differences in signal enhancement by
polarization transfer in DEPT.
IN VITRO NMR SPECTROSCOPY
After each experiment, rats were sacriﬁced using a focused
microwave ﬁxation device (Gerling Applied Engineering, Inc.,
Modesto, CA, USA) at 4 kW for 2 s. Brain tissue excluding cere-
bellum was immediately stored at −80˚C until extraction. Water-
soluble metabolites from brain and plasma samples were extracted
with 7% (v/v) perchloric acid (PCA) as previously described
(Duarte et al., 2007) and dried with a sample concentrator (Speed-
VacDNA120,ThermoFisher Scientiﬁc,Wohlen,Switzerland). The
dried extracts were dissolved in 2H2O (99.9% 2H, Sigma-Aldrich)
and 1.2 mmol sodium fumarate (Sigma-Aldrich) was added as
internal standard for quantiﬁcation by 1H NMR spectroscopy.
1H and 13C NMR spectra were acquired on a 14.1 T DRX-600
spectrometer equipped with a 5-mm cryoprobe (Bruker BioSpin
SA, Fallanden, Switzerland) as previously described (Duarte et al.,
2007). Peak areas were quantiﬁed by curve ﬁtting.
DETERMINATION OF METABOLIC FLUXES
Kinetic modeling of [1,6-13C]glucose metabolism was performed
with basis on the mathematical model of compartmentalized cere-
bral metabolism described by Gruetter et al. (2001). Figure 1
depicts metabolic pools and ﬂuxes deﬁned in our model, which is
detailed in Section“Appendix.”An alternative model was designed
to eliminate the non-measurable 13C enrichment of TCA cycle
intermediates (Uffmann and Gruetter, 2007).
Each model was ﬁtted to the 13C enrichment curves over time
using the Levenberg–Marquardt algorithm for non-linear regres-
sion, coupled to a Runge–Kutta method for non-stiff systems to
obtain numerical solutions of the ordinary differential equations
(see Appendix). Signiﬁcance of the ﬁtted parameters (ﬂuxes) was
inferred from t -statistics. F-statistics was used for assessment of ﬁt
quality and for inter-model comparison. Reliability of determined
ﬂuxes was evaluated by Monte-Carlo analysis, in which Gaussian
noise with the same variance of ﬁt residuals was added to the best
ﬁt and initial conditions were randomly generated within con-
ﬁdence interval of the obtained value. Typically, 500 simulated
datasets were created for each individual analysis. All numerical
procedures were performed in Matlab.
The estimated metabolic ﬂuxes are shown as mean ± SD, being
the SD resulting from Monte-Carlo simulations. Other results are
shown as mean± SEM of n = 5 experiments.
RESULTS
The speciﬁc protocol of 13C-enriched glucose infusion raised
plasma glucose from100 to 350 mg/dL in 5 min and then remained
constant (Figure 2A), leading to a step function in plasma glu-
cose FE of ∼70% (Figure 2B). Concentration of lactate in
plasma varied during the experiment as consequence of the vari-
able glucose infusion rate that aimed at a stable plasma glucose
level (Figure 2A). FE of lactate increased at the onset of [1,6-
13C]glucose and was maintained constant over time (Figure 2B),
and may contribute to brain metabolism. For example, at the
end of the experiment, the FE of plasma glucose and lactate were
0.67± 0.01 and 0.50± 0.01, respectively. FE in plasma alanine and
acetate increased over the experimental time course and seemed
to reach a steady-state after 300min, respectively achieving a FE of
0.45± 0.02 and 0.33± 0.01 (Figure 2C). Therefore, the inﬂux of
13C labeling from extra-cerebral lactate and acetate was included
in the model (see Appendix). Plasma alanine was considered to
have minor contribution to brain metabolism since it exists at only
11.2± 3.2% of lactate concentration (quantiﬁed in PCA extracts
of plasma samples by in vitro NMR spectroscopy). This is further
supported by the relative low rate of alanine transport into the
brain and contribution to metabolism (Bröer et al., 2007).
The in vivo spectral quality achieved at 14.1 T can be appreci-
ated from Figure 3. A major improvement was the increased sen-
sitivity relative to lower ﬁelds and the full separation of the carbon
positions of glutamate and glutamine C3 which was not possible
at, for example, 9.4 T (Henry et al., 2003b). The 13C resonances
of glucose, glutamate, glutamine, and aspartate were determined
with a temporal resolution of 5.3min (Figures 3 and 4). Total
concentration of these amino acids was determined in vivo and
found to be 8.5± 0.4μmol/g for glutamate, 5.1± 0.5μmol/g for
glutamine, and 2.4± 0.3μmol/g for aspartate.
In brain extracts, prepared at the end of the experiment, FE was
0.70± 0.02 for glucose, 0.53 ± 0.02 for lactate, and 0.54 ± 0.01 for
alanine. Therefore, a signiﬁcant dilution ﬂux V out must occur,
leading to different FE in brain glucose and the end products of
glycolysis, namely lactate. Lactate homeostasis resides in a balance
between production, consumption and exchange between brain
parenchyma, and extra-cerebral lactate equivalents. Plasma lac-
tate was labeled at a different enrichment than that of plasma
glucose (Figure 2), thus contributing to brain lactate through
V in. However, the redundancy between contributions of [1,6-
13C]glucose and [3-13C]lactate enriched at different levels to
metabolism in mitochondria leads to a high correlation between
V out, glucose transport (Tmax), and consumption (CMRglc)
(Figure 5). Therefore, glucose transport was determined from
the experimental data with a dynamic version of the reversible
Michaelis–Menten model described by Duarte et al. (2009b)
and transport parameters used to simulate glucose transport
that feeds the pyruvate pool: Tmax = 0.91± 0.03μmol/g/min,
CMRglc = 0.50± 0.02μmol/g/min, and K t = 0.32± 0.10 mM.
The constraint of parameters directly involved in glucose home-
ostasis was devoid of signiﬁcant effects on the remainingmetabolic
ﬂuxes, with the obvious exception of V out.
The compartmentalized model of brain metabolism previously
proposed (Gruetter et al., 2001) was adapted to include a non-
zero concentration of aspartate in the glial compartment and a
dilution factor at the level of glial acetyl-CoA (see Appendix).
Non-linear regression of the model to the determined 13C enrich-
ment curves is shown in Figure 4. Following the suggestion that
TCA cycle intermediates can be excluded from the mathematical
model, at least for the non-compartmentalized case (Uffmann and
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FIGURE 1 | Model of compartmentalized brain metabolism adapted
from Gruetter et al. (2001). Glucose transport is here represented byT glc.
CMRglc is the cerebral metabolic rate of glucose. Pyruvate (Pyr) originated
from glucose consumption is in fast equilibrium with lactate (Lac) that is
exchanged between neurons and glia and is diluted with extra-cerebral
lactate through V out/V in. V nPDH is the neuronal TCA cycle, V g +V PC is the
total glial TCA cycle, V PC is the rate of pyruvate carboxylase. In the glial
compartment, the dilution of label at the level of acetyl-CoA (AcCoA)
by glial speciﬁc substrates is accounted by V dil . TCA cycle intermediates
oxaloacetate (OAA) and 2-oxoglutarate (OG) exchange with aminoacids
through the exchange ﬂux V X. The apparent glutamatergic neurotransmission
(i.e., glutamate–glutamine cycle) is V NT and glutamine synthetase rate
is V GS. Finally, efﬂux of labeling from the metabolic system occurs through the
rate of glial glutamine loss V efﬂux. The superscripts g and n distinguish
metabolic pools or ﬂuxes in the glial and neuronal compartments,
respectively.
Gruetter, 2007), we further tested the ﬁt of such model (derived
in Appendix) with successful results. In any of the cases, the
non-linear regressionswere performedwithout imposing any con-
straint to the eight ﬂuxes of intermediary metabolism that were
estimated. Precision of the estimated ﬂuxes was determined by
Monte-Carlo simulations and the resulting probability was ﬁtted
with a gamma function that, for all estimated ﬂuxes, approached
a Gaussian distribution. For the sake of comparison, estimated
ﬂuxes with both models are shown in Table 1. As the increas-
ing number of experimental 13C enrichment time courses used in
the ﬁtting process may increase the accuracy of estimated ﬂuxes,
as suggested by numerical simulations (Shestov et al., 2007), we
ﬁtted both models providing or not the aspartate C2 and C3
turnover curves (Table 1).Although increased precisionwas found
to be associated with the number of ﬁtted 13C enrichment curves,
estimated ﬂuxes did not diverge signiﬁcantly.
For themost completemodel, i.e., includingTCAcycle interme-
diates andﬁtted to 13C enrichment curves of glutamate, glutamine,
and aspartate, the TCA cycle V TCA was 0.45± 0.01μmol/g/min
and 0.28± 0.02μmol/g/min the neuronal and glial compart-
ments, respectively. Notably, the ﬂux though the malate–aspartate
shuttle V x was in the same order of V TCA. Pyruvate carboxylation
V PC was 0.069± 0.004μmol/g/min, accounting for speciﬁc label-
ing of glutamate and glutamine C2. The neurotransmission ﬂux
V NT of 0.11± 0.01μmol/g/min is, in our model, the responsible
for labeling exchange between the two compartments. These
ﬂuxes were not statistically different between the different analyses
(Table 1).
DISCUSSION
Compartmentalized brain energymetabolismwas determined fol-
lowing infusion of [1,6-13C]glucose and direct detection of 13C
enrichment of brain metabolites by high resolution 13C NMR
spectroscopy at 14.1 T. High sensitivity was achieved in this
study and permitted to quantify 13C enrichment curves of brain
amino acid carbons with high reproducibility and to reliably
determine cerebral metabolic ﬂuxes, as indicated by the mean
error of 8% associated to the determined ﬂuxes (Table 1). For
the ﬁrst time to our knowledge, we used 13C turnover curves
determined in vivo in the rat brain for all aliphatic carbons of
glutamate, glutamine, and aspartate for metabolic modeling, sim-
ilarly to what was performed for the human brain (Gruetter
et al., 2001). This, together with the high temporal resolution
and long time course of the detected 13C enrichment, increased
the level of precision of the measured metabolic ﬂuxes (Shestov
et al., 2007). For the determined metabolic ﬂuxes, although simi-
lar results were obtained in the absence or inclusion of aspartate
13C enrichment curves in the ﬁtting process, precision generally
increased with the number of used turnover curves, especially
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FIGURE 2 | Concentration and fractional enrichment (FE) of plasma glucose, lactate, alanine, and acetate upon infusion of [1,6-13C]glucose. (A) Shows
glucose (ﬁlled symbols) and lactate (open symbols) concentration determined during the entire time course. (B) Depicts FE of glucose and lactate determined
by in vitro 1H NMR spectroscopy. FE of alternative brain substrates alanine and acetate were determined in 1H NMR spectra of plasma samples (C).
when TCA cycle intermediates are absent from the model (see
Table 1).
Uffmann and Gruetter (2007) previously demonstrated by
means of numerical simulations that the unknown in vivo 13C
enrichment time courses of TCA cycle intermediates can be
neglected using a single compartment model of brain metab-
olism. We now extended that model to include the two main
cerebral metabolic compartments (glial and neuronal compart-
ments) and found similar results in the absence or presence of
TCA cycle intermediates in the mathematical model. In fact, sim-
ilar metabolic ﬂuxes were estimated with the two approaches and
identical best ﬁt curves were obtained. However,without the inter-
mediates, increased correlation between the estimated ﬂuxes was
observed (Figure 5). This is caused by the fact thatmetabolic ﬂuxes
are directly combined in products and quotients in the derived
equations.
Recent publications restricted the analysis of cerebral interme-
diary metabolism by in vivo 13C NMR spectroscopy to resonances
C4 and C3 and disregarded the C2 of glutamate and glutamine,
which may be principally due to low resolution of acquired 13C
NMR spectra or to the use of indirect detection of 13C enrichment
in 1H NMR spectra (de Graaf et al., 2003; Patel et al., 2010; van
Eijsden et al., 2010; Xin et al., 2010). Indirect 13C detection has the
great advantage of higher sensitivity but the drawback of lower
spectral resolution characteristic of 1H NMR spectroscopy even at
14.1 T (Xin et al., 2010). Our results show that, with increased sen-
sitivity at highmagnetic ﬁeld strengths,direct 13Cdetectionmaybe
preferred. We achieved good time resolution for aliphatic carbons
of glutamate and glutamine (the most concentrated metabolites
appearing in the 13C spectra of the brain) with high reproducibil-
ity between all animals studied. The data further suggested that
we could reduce the time span of C4 enrichment curves of these
amino acids to 3 min without losing the consistency of the 13C
time course measurement (data not shown). Conversely, the 13C
enrichment curves could be acquired from a volume of interest
smaller than 320μL (used in this study). In our experimental con-
ditions,wedetermined the turnover curves for all aliphatic carbons
of glutamate, glutamine, and aspartate and provided them for the
non-linear ﬁt of the mathematical model (Figure 4).
The simultaneous determination of 13C-enriched glucose con-
centrations in plasma and brain allows measuring glucose trans-
port. Notably, high correlation was found between glucose trans-
port (Tmax), consumption (CMRglc), and label exchange before
mitochondrial oxidation (V out). Therefore, glucose transport was
analyzed as described by Duarte et al. (2009b) and the obtained
parameters were used to simulate brain glucose enrichment and
concentration as input for themetabolicmodel.However,by simu-
latingTmax andCMRglc, correlation betweenV out andother ﬂuxes
increased.V out, alongwithV in, representmetabolic exchangewith
other metabolites fueling brain metabolism, such as free amino
acids (e.g., Bröer et al., 2007; Boumezbeur et al., 2010), and inter-
action of glycolysis with other brain pathways like the pentose
phosphate shunt (e.g., Dusick et al., 2007). In fact, the brain is
capable of lactate uptake and metabolism (e.g., Dienel and Cruz,
2009; Gallagher et al., 2009; Boumezbeur et al., 2010). Exchange
between extra-cerebral lactate with pyruvate is modeled by V in
and V out and a net gain or loss of lactate concentration is taken
into account by the ratio of V in to V out. FE of brain lactate was
signiﬁcantly lower than that of the precursor glucose. Assuming
that lactate is in fast exchange with the direct end product of gly-
colysis, pyruvate, and thus achieves similar FE, there would be a
signiﬁcant diversion of labeling between glucose entry in the brain
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FIGURE 3 |Typical in vivo 13C NMR spectra acquired at 14.1T from a
320-μL volume in the rat brain upon infusion of [1,6-13C]glucose.
(A) Shows the initial 100min of a time course of 13C enrichment of brain
metabolites from plasma [1,6-13C]glucose, with a temporal resolution of
5.3min (128 scans with TR of 2.5 s). The spectrum in (B) was acquired
for 1.8 h, starting 3.5 h after the onset of [1,6-13C]glucose infusion.
(C) Depicts the expansion of (B) from 26 to 38 ppm, where are visible
the multiplets originated by the different isotopomers of glutamine (Gln),
glutamate (Glu), and aspartate (Asp). For resolution enhancement,
Lorentzian–Gaussian apodization was applied before Fourrier transformation
[lb= 7, sb= 0.12, and sbs= 0.02 for (A); sb= 0.12 and sbs= 0.02
for (B,C)].
and oxidation in the mitochondrial TCA cycle. In fact, a signiﬁcant
V out was determined and, additionally, it was different from V in
that represents lactate utilization fromextra-cerebral sources (note
that plasma lactate was also enriched). Since V out >V in, not all
glucose consumption rate (CMRglc) follows complete oxidation,
i.e. CMRglc(ox). Our results indicate that only 78 ± 4% of the total
glucose phosphorylation is oxidized in the TCA cycle, which is
comparable to previous ﬁndings (discussed in Siesjo, 1978; Dienel
and Hertz, 2001).
Different relative FE was observed in carbons of glutamate
relative to glutamine. For example, at the end of the experi-
ment, while glutamate C2 enrichment approaches that of C3
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FIGURE 4 | Concentration of enriched glutamate (A), glutamine (B), and
aspartate (C) carbons detected in vivo during infusion of
[1,6-13C]glucose. For glutamate and glutamine, blue, green, and red lines
represent best ﬁt to the 13C enrichment curves for C4, C3, and C2,
respectively. For aspartate, green and red lines depict C2 and C3. Exact
overlap was observed for the best ﬁt curves with both metabolic models, i.e.,
with and without the inclusion of TCA cycle intermediates. This particular ﬁts
were performed with the inclusion of aspartate resonances. Although some
experiments were conducted over a longer period (Figure 2), the data used
for ﬂux estimation was averaged for 280min. (D) Shows the concentration of
glucose C6 determined in vivo and the ﬁt result of the dynamic reversible
Michaelis–Menten model described in Duarte et al. (2009b).
FIGURE 5 | Correlation matrices showing the covariances between
estimated metabolic fluxes. Metabolic modeling was performed with all
measurable 13C enrichment curves for glutamate, glutamine, and aspartate
either including (left plots) or excluding (right plots) TCA cycle intermediate
pools. Due to high correlation found betweenT max, CMRglc, and V out,
glucose transport kinetics was then determined as described in Duarte
et al. (2009b) and simulated in the present model (bottom matrices).
(Figure 4A), glutamine C2 is close to C4 and different from that
of C3 (Figure 4B). This would only be possible if, in addition to
the glial V PC labeling C2 of glutamate and glutamine, the TCA
cycle precursor pools in glial and neuronal compartments display
different FE. This is consistent with alternative glial speciﬁc sub-
strates fueling brain metabolism, namely acetate (Badar-Goffer
et al., 1990; Cerdán et al., 1990), fatty acids (Ebert et al., 2003),
and ketone bodies (Künnecke et al., 1993), which are oxidized
to glial acetyl-CoA. Therefore, a dilution factor was introduced
at the level of glial acetyl-CoA (V dil). V dil not only acts as dilu-
tion factor for glial acetyl-CoA but can also incorporate 13C label
from blood-born acetate (Figure 2C, which was considerable at
the end of the experiment (FE= 0.33± 0.01). This dilution factor
also accounts for eventual glial speciﬁc metabolic processes that
deviate 13C labeling fromoxidation in theTCAcycle, such as glyco-
gen synthesis (Gruetter, 2003). V dil was thus found to be slightly
higher but not substantially different from the acetate consump-
tion rate determined in the rat brain upon with infusions of 13C
enriched acetate (Deelchand et al., 2009). This glial labeling dilu-
tion of the acetyl-CoA pool through V dil was positively correlated
to the apparent neurotransmission V NT as they are both respon-
sible for the observed difference in C4 labeling between glutamate
and glutamine.
One should note that, since glutamine and glutamate aremostly
located in glial cells and neurons, respectively, V dil also accounts
for the 13C labeling dilution between the two amino acids. Because
part of glutamine may be undetected in in vivo 1H NMR spectra
(e.g., Hancu and Port, 2011), we determined total glutamine rela-
tive to that of glutamate using resonance intensities and FEs from
the 13C NMR spectra. Therefore, a total glutamine concentration
different from5.1± 0.5μmol/g (measured in this study),may lead
to a modiﬁcation of V dil.
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Table 1 | Cerebral metabolic fluxes (in μmol/g/min) determined either including or excludingTCA cycle intermediates.
Curves fitted WithTCA cycle intermediates WithoutTCA cycle intermediates
Glu+Gln Glu+Gln+Asp Glu+Gln Glu+Gln+Asp
DETERMINED FLUXES
V out 0.36± 0.05 0.42± 0.04 0.37± 0.06 0.41± 0.05
V PC 0.070± 0.004 0.069± 0.004 0.069± 0.005 0.067± 0.004
V nPDH 0.44± 0.01 0.45± 0.01 0.46± 0.02 0.46± 0.01
V g 0.23± 0.02 0.21± 0.02 0.23± 0.03 0.21± 0.02
V nX 0.76± 0.07 0.91± 0.09 0.83± 0.11 0.99± 0.12
V gX 0.17± 0.06 0.16± 0.05 0.23± 0.12 0.25± 0.16
V NT 0.12± 0.01 0.11± 0.01 0.11± 0.01 0.10± 0.01
V dil 0.76± 0.15 0.66± 0.10 0.64± 0.13 0.55± 0.08
CALCULATED FLUXES
V gTCA 0.30± 0.02 0.28± 0.02 0.30± 0.03 0.27± 0.02
V in 0.19± 0.05 0.22± 0.05 0.21± 0.07 0.24± 0.05
V GS 0.19± 0.01 0.18± 0.01 0.18± 0.01 0.17± 0.01
CMRglc(ox) 0.41± 0.02 0.39± 0.02 0.42± 0.04 0.40± 0.02
Determinations were made with 13C enrichment curves from glutamine (Gln), glutamate (Glu), and eventually aspartate (Asp). Estimated values are presented with
two signiﬁcant digits and the associated SD was determined by Monte-Carlo analysis with at least 500 simulations. Calculated ﬂuxes are deﬁned in the Section
“Appendix.”
The neuronal and glial V TCA were 0.45± 0.01 and
0.28± 0.02μmol/g/min, respectively. This means that glial V TCA
accounts for 38± 3%of totalmitochondrial oxidativemetabolism,
from which 25± 1% isV PC.V PC is further increased upon higher
cerebral activity in the conscious rat (Oz et al., 2004) and reduced
under isoelectricity (Sibson et al., 1998; Choi et al., 2002). This
substantial pyruvate carboxylation ﬂux supports the active role of
glial cells in their metabolic relationship with neurons, especially
during synaptic transmission. In fact, in cultured astrocytes, extra-
cellular potassium was suggested to stimulate bicarbonate inﬂux
(Brookes and Turner, 1994), which can induce anaplerosis (Gam-
berino et al., 1997), and to increase glutamine content (Brookes
and Turner, 1993). In our model, V GS results from the addition
of V PC to V NT and thus depicts this coupling of anaplerosis to
glutamine synthesis, both occurring in the glial compartment.
To maintain mass balance in the glutamine–glutamate cycle, exit
of labeling from the cycle was modeled as V efﬂux, representing
other fates of glutamate and glutamine (McKenna, 2007). It is
proposed that astrocytic glycolysis sustains glutamatergic neuro-
transmission and the resulting lactate is shuttled to neurons for
oxidative metabolism (Pellerin and Magistretti, 1994; Magistretti
et al., 1999). This hypothesis considers that astrocytic metabo-
lism is mainly glycolytic, which would be sufﬁcient to meet the
energetic requirements of glutamate uptake and glutamine syn-
thesis in the neurotransmission process (Magistretti et al., 1999).
However, clearance of glutamate could be fueled by mitochondrial
oxidative phosphorylation in astrocytes (Dienel and Hertz, 2001).
In accordance, the present results suggest that a substantial part
of mitochondrial oxidation of glycolytic pyruvate takes place in
the glial compartment, as observed in the conscious rat (Oz et al.,
2004).
The exchange between amino acids in the cytosol and the mito-
chondrial matrix, where the TCA cycle takes place, is mediated
by the malate–aspartate shuttle and responsible for most labeling
exchange between glutamate or aspartate and their oxo-acids 2-
oxoglutarate and oxaloacetate, represented by V x (Gruetter et al.,
2001). V x has frequently been assumed to be much larger than
V TCA (e.g., Hyder et al., 1996, 1997; Sibson et al., 1998), i.e.,
V TCA/V x = 0, which allows simpliﬁcation of the mathematical
models but may lead to underestimation of TCA cycle ﬂuxes (see
Uffmann and Gruetter, 2007). This assumption implies that 13C
enrichment of glutamate and aspartate resembles that of OG and
OAA, respectively, which may not be accurate (Gruetter et al.,
2001). Experimental evidence shows that this ﬂux could be either
in the range of the TCA cycle ﬂux (e.g., Gruetter et al., 2001; Oz
et al., 2004) or effectively larger (e.g., de Graaf et al., 2004; Yang
et al., 2009). In the rat brain under α-chloralose, we determined
13C enrichment curves with increased sensitivity and estimated a
ﬁnite V x that is on the same order of V TCA in both neurons and
glia. Although from all estimated ﬂuxes, glial V x was the poorest
estimated, i.e., with larger relative SD, all numerical simulations
resulted in a V
g
X on the order of V
g
TCA. To our knowledge this is
the ﬁrst time thatV x is simultaneously determined in neurons and
glia. Half of the total V TCA, that represents oxidative glucose con-
sumption CMRglc(ox), was found to be 0.39± 0.02μmol/g/min
(see Table 1), in agreement to other determinations by 13C NMR
(Henry et al., 2002), or to measurements of CMRO2 by 17O NMR
spectroscopy (Zhu et al., 2002) and CMRglc by autoradiography
(Ueki et al., 1992; Nakao et al., 2001) in rats under α-chloralose
anesthesia.
The neurotransmission ﬂux V NT represents the ﬂow of 13C
labeling in the glutamate–glutamine cycle and was now deter-
mined to be 0.11± 0.01μmol/g/min (see Table 1) that is sim-
ilar to that reported by (Sibson et al., 1998) for the rat brain
under α-chloralose anesthesia. It should however be noted that
in the present work, V NT was determined with higher precision
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as suggested by an SD below 10%. The use of the C2 turnover
curves of both glutamate and glutamine greatly contributed to
the precision in the estimation of V NT by receiving direct 13C
labeling input through pyruvate carboxylation that occurs in the
glial compartment. A positive correlation was observed between
V NT and the dilution of glial acetyl-CoA V dil (Shen et al., 2009),
which resides in the fact that V dil creates a difference between the
FEs of glutamine and glutamate while V NT is responsible for its
dissipation.
In vitro studies suggest the existence of high fumarase activ-
ity randomizing 13C labeling from oxaloacetate (Sonnewald et al.,
1993; Merle et al., 1996). Direct injection of [1-14C]pyruvate in
the neocortex of mice labels glutamate and glutamine, which
would only occur with pyruvate carboxylation and a notable rate
through fumarase (Nguyen et al., 2007). In an alternative model,
ﬂux through fumarase (V fum) allowing labeling exchange between
OAA C3 and C2 was included. V fum was detected but poorly
determined, i.e., presented high relative SD, and was not signif-
icantly different from zero, as in a previous in vivo study (Oz et al.,
2004). This is likely due to the high correlation of V fum to V PC
that alone accounts for the difference in C2 and C3 enrichment
of glutamate and glutamine. The fact that aspartate, which is in
exchange with OAA, is mostly located in neurons (discussed in
Gruetter et al., 2001), makes it insensitive to this ﬂux. In accor-
dance to the primary location of aspartate to neurons, NMR spec-
troscopy of brain extracts at the end of the experiment revealed
similar FE for C3 and C2 of aspartate in our study (0.52± 0.02
and 0.52± 0.01, respectively). However, the signiﬁcant difference
between 13C enrichment of carbons C2 and C3 of glutamate and
glutamine at steady-state is in agreement with lowV fum compared
to V PC.
Pyruvate recycling was suggested to occur in the brain (e.g.,
Cerdán et al., 1990; Sonnewald et al., 1996; Waagepetersen et al.,
2002; Serres et al., 2007; Scaﬁdi et al., 2010). This process would
lead to enrichment of pyruvate C2 and consequently lactate C2
and, in fact, FE of lactate C2 in brain extracts at the end of the
experiment was 0.029± 0.001. Although signiﬁcant compared to
the natural abundance of 0.011 (P < 0.01 with one-sample t test),
it was much lower than the enrichment of C3 and therefore negli-
gible. This pathway was suggested to be mainly used for complete
oxidation of glutamate or glutamine in the TCA cycle and to occur
in cultured astrocytes but not in neurons and in co-cultures of
both (Sonnewald et al., 1996; Waagepetersen et al., 2002). This
is in agreement with the lack of evidence for substantial pyru-
vate recycling in vivo. In addition, high glucose concentration
may lead to reduction of the pyruvate recycling ﬂux (discussed
in Waagepetersen et al., 2002) and some C2 enrichment observed
in vivo may be of systemic origin due to scrambling of 13C labeling
in tissues such as the liver (discussed in Serres et al., 2007).
CONCLUSION
The present work experimentally demonstrates that reliable deter-
mination of 13C enrichment curves with high temporal resolu-
tion increases the precision of estimated metabolic ﬂuxes. Addi-
tionally, precision increases with the number of experimentally
measured turnover curves. Furthermore, we provide experimen-
tal evidence that non-measurable 13C enrichment of TCA cycle
intermediates is not required for ﬂux estimation, but increased
correlation between the resulting ﬂuxes must be expected. We
found a substantial glial oxidative metabolism, part being dri-
ven through pyruvate carboxylase, which corresponds to more
than half of the neuronal TCA cycle rate. This is consistent
with the active role of astrocytes in the support of glutamatergic
neurotransmission.
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APPENDIX
KINETIC MODEL OF [1,6-13C]GLUCOSE METABOLISM
The mathematical model of compartmentalized cerebral metabolism was adapted from Gruetter et al. (2001) and this publication
should be consulted for an exhaustive description of the model. In Figure 1 are depicted the metabolic pools and ﬂuxes in glia and
neurons used to deﬁne the model.
Metabolic but not isotopic steady-state was assumed over the time course of [1,6-13C]glucose infusion. Metabolite concentrations
determined in vivo (all in μmol/g) were 8.5± 0.4 for glutamate, 5.1± 0.5 for glutamine, and 2.4± 0.3 for aspartate. The remaining
concentrations required for the model were assumed. Acetyl-CoA and TCA cycle intermediates were considered to be 0.1 μmol/g in
both compartments. Pyruvate was assumed to occur at 10% of lactate concentration (e.g., Mintun et al., 2004) that was measured
as 0.7± 0.1μmol/g. Neurons were assumed to retain 90% of total glutamate and aspartate pools, while glial cells contain 90% of
total observed glutamine concentration. Due to fast exchange between the two compartments, a single virtual pool of pyruvate was
considered to be shared by neurons and glia. This also implies that isotopic enrichment in pyruvate is equivalent to lactate, which is
detectable.
At metabolic steady-state, the fraction of glucose oxidation entering the TCA cycle is (V nTCA +V gTCA +VPC)/2 that we call CMRglc(ox).
Similarly, total glucose consumption (CMRglc) is CMRglc(ox) + (V out −V in)/2.When the outﬂow (V out) of labeling at the level of lactate
equals the inﬂow (V in) from extra-cerebral lactate, the total glucose consumption is used for oxidation in the TCA cycle.





TCA is V g +V PC, corresponding to the total oxidation of one molecule of pyruvate.
The ﬂux through neuronal glutaminase is V NT. In the glia, glutaminase was neglected because the net ﬂux of 13C follows the
direction of the apparent neurotransmission cycle V NT. The net loss of 13C labeling was modeled as V efﬂux and mass conservation sets
it equivalent to the anaplerotic ﬂux through pyruvate carboxylase V PC. Thus V GS =V NT +V PC.
Glucose transport across the BBB was deﬁned using a reversible Michaelis–Menten kinetics as previously described for the rat brain
(Duarte et al., 2009b). Therefore, brain glucose (Gbrain) is given by the following expression:
dGbrain
dt
= Tmax Gplasma(t ) − Gbrain(t )/Vd
Kt + Gbrain(t )/Vd + Gplasma(t ) − CMRglc
where Tmax is the apparent maximal transport rate, K t is the apparent Michaelis constant for glucose transport, CMRglc is the cerebral
metabolic rate of glucose consumption, and V d is the physical volume for glucose distribution in the brain (0.77mL/g, as in Duarte




13Gplasma(t ) − 13Gbrain(t )/Vd




Although brain glucose can divert to other pathways, it is consumed mainly through glycolysis and the 13C enrichment in C1 and C6
originates the C3 of pyruvate. Pyruvate was considered to be in fast equilibrium with lactate that is exchanged between compartments










− (Vout + V nTCA + V gTCA + VPC) 13Pyr3(t )Pyr
Note that, in the model, total concentration of extra-cerebral lactate (Lac) may vary over time in accordance to the observed plasma
lactate levels (Figure 2). Transport of lactate into the brain was simulated with a reversible Michaelis–Menten kinetics as described by
Boumezbeur et al. (2010) leading to enrichment of 13Lac from plasma lactate. Therefore, alteration of plasma lactate levels is reﬂected in
brain lactate concentration. However, total concentration of pyruvate remains invariable because V in is constant under the assumption
of metabolic steady-state.
In peripheral tissues, metabolism of [1,6-13C]glucose produces [3-13C]lactate that is released to the blood stream. Incorporation of
13C from blood-born lactate (Lac3) into brain metabolism may occur (e.g., Dienel and Cruz, 2009; Gallagher et al., 2009; Boumezbeur
et al., 2010) and is accounted by V in in the equations of brain pyruvate. In addition, V out represents 13C labeling dilution from the
glycolysis, either by lactate release from brain parenchyma or by glucose utilization in alternative pathways.
Since scrambling of blood 13C glucose and lactate enrichment may occur during peripheral metabolism and enrich carbons other
than glucose C1 and C6 and lactate C3. These carbons are metabolized and lead to enrichment of pyruvate C2 that, by pyruvate
carboxylation, contributes to direct enrichment of oxaloacetate C2. The following expression was deﬁned but, in the absence of sub-











− (Vout + V nTCA + V gTCA + VPC) 13Pyr2(t )Pyr .
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Neuronal compartment
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( 13OGn4(t ) + 13OGn3(t )
OGn
)
− (V nPDH + V nx ) 13OAAn3(t )OAAn + V nx
13Aspn3(t )
Aspn

































The glia comprises the additional ﬂuxes through pyruvate carboxylase (V PC) and glutamine synthesis (V GS) (see Gruetter et al., 2001).
In the glial compartment, a dilution factor was introduced at the level of acetyl-CoA (V dil), accounting for possible
13C label dilution
by in vivo metabolism of acetate (Badar-Goffer et al., 1990; Cerdán et al., 1990; Deelchand et al., 2009), fatty acids (Ebert et al., 2003),















Vdil + Vg + VPC
) 13AcCoAg2(t )
AcCoAg
Extra-cerebral acetate may contribute to brain metabolism and therefore 13Ac represents blood-born 13C acetate (Figure 2C). Transport
of acetate into the brain was simulated as described by Deelchand et al. (2009) leading to enrichment of 13Ac from plasma acetate.









































































































Vg + VPC + V gx
) 13OAAg3(t )
OAAg
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REMOVING TCA CYCLE INTERMEDIATES FROM THE MODEL
Simpliﬁcation of the mathematical model of cerebral metabolism was used to remove TCA cycle intermediates from mathematical
expressions, as previously suggested by simulations (Uffmann and Gruetter, 2007).
For the sake of example, the combination of equations for neuronal glutamate C4 ( d
13Glun4
dt ) and 2-oxoglutarate C4 (
d13OGn4
dt ) can be
used to eliminate terms with
13OGn4(t )






























Because the concentration of glutamate is much larger than that of the TCA cycle intermediates, the increase in concentration of

























































From this expression, the term with oxaloacetate (OAA) can be removed by intermediary of the respective differential equation of
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13Glun4(t ) + 13Glun3(t )
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V nPDH + V nx
13Aspni (t )
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For the concentration of 13C in carbons of glial aspartate, the following equation is obtained, where i can be either the position 2
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Vg + VPC + V gx
13Pyri(t )
Pyr
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